{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:36:27Z","timestamp":1761676587226,"version":"3.40.5"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Wonkwang University in 2015"}],"content-domain":{"domain":["ejradiology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ejrad.2018.02.032","type":"journal-article","created":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T13:46:37Z","timestamp":1519739197000},"page":"95-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B"],"prefix":"10.1016","volume":"102","author":[{"given":"Jung Hun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youe Ree","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy Mok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Hyun","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Young","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2634-8510","authenticated-orcid":false,"given":"Kwon-Ha","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ejrad.2018.02.032_bib0005","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s11547-016-0669-7","article-title":"Comparison of the effect of region-of-interest methods using gadoxetic acid-enhanced MR imaging with diffusion-weighted imaging on staging hepatic fibrosis","volume":"121","author":"Ding","year":"2016","journal-title":"Radiol. Med."},{"key":"10.1016\/j.ejrad.2018.02.032_bib0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejrad.2018.02.032_bib0015","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1056\/NEJM200102083440610","article-title":"Is liver fibrosis reversible","volume":"344","author":"Bonis","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejrad.2018.02.032_bib0020","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejrad.2018.02.032_bib0025","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu. Rev. Pathol."},{"issue":"May","key":"10.1016\/j.ejrad.2018.02.032_bib0030","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/hep.25512","article-title":"NgIO Sequential alterations of miRNA expression in hepatocellular carcinoma development and venous metastasis","volume":"55","author":"Wong","year":"2012","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.ejrad.2018.02.032_bib0035","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.cgh.2013.07.034","article-title":"Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis","volume":"11","author":"Singh","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejrad.2018.02.032_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhep.2008.10.014","article-title":"Liver biopsy: the best, not the gold standard","volume":"50","author":"Bedossa","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejrad.2018.02.032_bib0045","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy","volume":"49","author":"Rocckey","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.ejrad.2018.02.032_bib0050","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2214\/ajr.173.3.10470885","article-title":"Viral-induced cirrhosis: grading of severity using MR imaging","volume":"173","author":"Ito","year":"1999","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ejrad.2018.02.032_bib0055","doi-asserted-by":"crossref","first-page":"e114224","DOI":"10.1371\/journal.pone.0114224","article-title":"Histogram analysis of gadoxetic acid enhanced MRI for quantitative hepatic fibrosis measurement","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejrad.2018.02.032_bib0060","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1148\/radiol.10092065","article-title":"Cirrhotic rat liver: reference to transporter activity and morphologic changes in bile canaliculi\u2014gadoxetic acid-enhanced MR imaging","volume":"256","author":"Tsuda","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2018.02.032_bib0065","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3348\/kjr.2017.18.3.444","article-title":"Quantitative measurement of hepatic fibrosis with gadoxetic acid\u2013enhanced magnetic resonance imaging in patients with chronic hepatitis B infection: comparison study of aspartate aminotransferase to platelet ratio index and fibrosis-4 index","volume":"18","author":"Lee","year":"2017","journal-title":"Korean J. Radiol."},{"key":"10.1016\/j.ejrad.2018.02.032_bib0070","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.dld.2007.10.011","article-title":"Aspartate aminotransferase to platelet ratio index (APRI) can predict liver fibrosis in chronic hepatitis B","volume":"40","author":"Shin","year":"2008","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.ejrad.2018.02.032_bib0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12876-016-0423-6","article-title":"Development of a transgenic mouse model of hepatocellular carcinoma with a liver fibrosis background","volume":"16","author":"Chung","year":"2016","journal-title":"BMC Gastroenterol."},{"issue":"Suppl. 1","key":"10.1016\/j.ejrad.2018.02.032_bib0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000333261","article-title":"Controversies in surveillance and early diagnosis of hepatocellular carcinoma","volume":"81","author":"Kim","year":"2011","journal-title":"Oncology"},{"key":"10.1016\/j.ejrad.2018.02.032_bib0085","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/1097-0142(19891115)64:10<2117::AID-CNCR2820641024>3.0.CO;2-7","article-title":"Elevations in serum alpha fetoprotein levels in patients with chronic hepatitis B","volume":"64","author":"Di Bisceglie","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.ejrad.2018.02.032_bib0090","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3748\/wjg.14.1652","article-title":"Natural history of hepatitis-related hepatocellular carcinoma","volume":"14","author":"But","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejrad.2018.02.032_bib0095","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1148\/radiol.10100621","article-title":"Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion weighted MR imaging\u2014preliminary observations","volume":"259","author":"Watanabe","year":"2011","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.ejrad.2018.02.032_bib0100","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/jmri.25288","article-title":"Hepatic enhancement of Gd-EOB-DTPA enhanced 3 Tesla MR imaging: assessing severity of liver cirrhosis","volume":"44","author":"Lee","year":"2016","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.ejrad.2018.02.032_bib0105","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1148\/radiol.13122482","article-title":"Liver fibrosis: histopathologic and biochemical influences on diagnostic efficacy of hepatobiliary contrast-enhanced MR imaging in staging","volume":"269","author":"Feier","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2018.02.032_bib0110","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00330-015-3830-0","article-title":"The diagnostic efficacy of quantitative liver MR imaging with diffusion-weighted, SWI, and hepatospecific contrast-enhanced sequences in staging liver fibrosis\u2013a multiparametric approach","volume":"26","author":"Feier","year":"2016","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ejrad.2018.02.032_bib0115","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.crad.2015.04.014","article-title":"Liver fibrosis staging using T1 mapping on gadoxetic acid-enhanced MRI compared with DW imaging","volume":"70","author":"Ding","year":"2015","journal-title":"Clin. Radiol."},{"issue":"August (26)","key":"10.1016\/j.ejrad.2018.02.032_bib0120","article-title":"Staging liver fibrosis in chronic hepatitis B with T1 relaxation time index on gadoxetic acid-enhanced MRI: comparison with aspartate aminotransferase-to-platelet ratio index and FIB-4","author":"Yang","year":"2016","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.ejrad.2018.02.032_bib0125","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1148\/radiol.14140313","article-title":"Advanced fibrosis: correlation between pharmacokinetic parameters at dynamic gadoxetate enhanced MR imaging and hepatocyte organic anion transporter expression in rat liver","volume":"274","author":"Lagadec","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.ejrad.2018.02.032_bib0130","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1124\/dmd.110.032862","article-title":"Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters","volume":"38","author":"Leonhardt","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejrad.2018.02.032_bib0135","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1016\/j.ejrad.2011.01.020","article-title":"Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers","volume":"80","author":"Tamada","year":"2011","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.ejrad.2018.02.032_bib0140","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.ejrad.2013.05.033","article-title":"Impact of liver cirrhosis on liver enhancement at Gd-EOB-DTPA enhanced MRI at 3 Tesla","volume":"82","author":"Verloh","year":"2013","journal-title":"Eur. J. Radiol."},{"issue":"13","key":"10.1016\/j.ejrad.2018.02.032_bib0145","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.3748\/wjg.v21.i13.3928","article-title":"Diagnostic value of PIVKA-II, and alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma","volume":"21","author":"In Seo","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejrad.2018.02.032_bib0150","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1440-1746.2001.02470.x","article-title":"Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America","volume":"16","author":"Tong","year":"2001","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejrad.2018.02.032_bib0155","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ejrad.2018.02.032_bib0160","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"European Organisation for Research and Treatment of Cancer. EASL EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"European Association for the Study of the Liver","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejrad.2018.02.032_bib0165","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12072-010-9165-7","article-title":"Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma","volume":"4","author":"Omata","year":"2010","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.ejrad.2018.02.032_bib0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1872-034X.2007.00216.x","article-title":"Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan","volume":"38","author":"Makuuchi","year":"2008","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.ejrad.2018.02.032_bib0175","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/hep.26739","article-title":"On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir","volume":"59","author":"Wong","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.ejrad.2018.02.032_bib0180","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1478-3231.2010.02348.x","article-title":"Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-\u03b3-carboxyprothrombin","volume":"31","author":"Inagaki","year":"2011","journal-title":"Liver Int."},{"key":"10.1016\/j.ejrad.2018.02.032_bib0185","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1134\/S0006297908050039","article-title":"Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis","volume":"73","author":"Gurtsevitch","year":"2008","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.ejrad.2018.02.032_bib0190","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejrad.2018.02.032_bib0195","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/aje\/155.4.323","article-title":"Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women","volume":"155","author":"Donato","year":"2002","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ejrad.2018.02.032_bib0200","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/157488807779317062","article-title":"Telomerase activation in liver regeneration and hepatocarcinogenesis: dr. Jekyll or Mr. Hyde?","volume":"2","author":"Wege","year":"2007","journal-title":"Curr. Stem Cell Res. Ther."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X18300792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X18300792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T16:21:49Z","timestamp":1535041309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X18300792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":40,"alternative-id":["S0720048X18300792"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2018.02.032","relation":{},"ISSN":["0720-048X"],"issn-type":[{"type":"print","value":"0720-048X"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2018.02.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}